Leapfrogging with technology: introduction of a monitoring platform to support a large-scale Ebola vaccination program in Rwanda

References

• World Health Organization. Immunization, vaccines and biologicals. Global Vaccine Action Plan 2011–2020. 2020 [accessed 2021 Jan 19]. https://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/ .
   Google Scholar
• World Health Organization. Ebola virus disease in African countries, Version 4. 2020 Jan 30 [accessed 2021 Jan 19]. https://www.who.int/medicines/news/JJEVD_VxRoadmap2020.pdf?ua=1 .
   Google Scholar
• Hardt K, Bonanni P, King S, Santos JI, El-Hodhod M, Zimet GD, Preiss S. Vaccine strategies: optimising outcomes. Vaccine. 2016;34:6691–99. doi:10.1016/j.vaccine.2016.10.078.
   PubMed Web of Science ®Google Scholar
• Usman S, Bologna L, Stamidis KV. The CORE Group Partners Project in North East Nigeria: community engagement strategies to combat skepticism and build trust for vaccine acceptance. Am J Trop Med Hyg. 2019;101(4_Suppl):68–73. doi:10.4269/ajtmh.19-0143.
   PubMed Web of Science ®Google Scholar
• Frederiksen LSF, Zhang Y, Foged C, Thakur A. The long road toward COVID-19 herd immunity: vaccine platform technologies and mass immunization strategies. Front Immunol. 2020;11:1817. doi:10.3389/fimmu.2020.01817.
   PubMed Web of Science ®Google Scholar
• Dumit EM, Novillo-Ortiz D, Contreras M, Velandia M, Danovaro-Holliday MC. The use of eHealth with immunizations: an overview of systematic reviews. Vaccine. 2018;36(52):7923–28. doi:10.1016/j.vaccine.2018.06.076.
   PubMed Web of Science ®Google Scholar
• Ross A, Jain A, Reisman J. A hybrid fingerprint matcher. Pattern Recognit. 2003;36:1661–73. doi:10.1016/S0031-3203(02)00349-7.
   Web of Science ®Google Scholar
• Saini R, Rana N. Comparison of various biometric methods. Int J Adv Sci Eng Technol. 2014;2:24–30.
   Google Scholar
• Cresswell KM, Sheik A. Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies. J Allergy Clin Immunol. 2008;121:1112–17. doi:10.1016/j.jaci.2007.12.1180.
   PubMed Web of Science ®Google Scholar
• Odei-Lartey E, Boateng D, Danso S, Kwarteng A, Abokyi L, Amenga-Etego S, Gyaase S, Asante KP, Owusu-Agyei S. The application of a biometric identification technique for linking community and hospital data in rural Ghana. Glob Health Action. 2016;9:29854. doi:10.3402/gha.v9.29854.
   PubMed Web of Science ®Google Scholar
• UNICEF. Data for children: faces, fingerprints & feet. Guidance on assessing the value of including biometric technologies in UNICEF-supported programs. 2019 Jul.
   Google Scholar
• Jain AK, Ross A, Prabhakar S. An introduction to biometric recognition. IEEE Trans Circuits Syst Video Technol. 2004;14(1):4–20. doi:10.1109/TCSVT.2003.818349.
   Web of Science ®Google Scholar
• Grother P, Matey JR, Tabassi E, Quinn GW, Chumakov M. Temporal stability of iris recognition accuracy, IREX VI K National Institute of Standards and Technology (NIST) Interagency Report 7948. 2013 [accessed 2021 Jan 19]. http://nvlpubs.nist.gov/nistpubs/ir/2013/NIST.IR.7948.pdf .
   Google Scholar
• Jain AK, Arora SS, Best-Rowden L, Cao K. Biometrics for child vaccination and welfare: persistence of fingerprint recognition for infants and toddlers. [accessed 2020 Oct]. http://biometrics.cse.msu.edu/Publications/Fingerprint/Jainetal_BiometricsChildVaccinationWelfare_MSUTechRepMSU-CSE-15-7.pdf ..
   Google Scholar
• Yoon S, Jain AK. Longitudinal study of fingerprint recognition. Proc Natl Acad Sci USA. 2015;112(28):8555–60. doi:10.1073/pnas.1410272112.
   PubMed Web of Science ®Google Scholar
• European Commission Joint Research Centre. Fingerprint recognition for children. Final report. Institute for the Protection and Security of the Citizen and Digital Citizen Security Unit; 2013 [accessed 2021 Jan 19]. http://publications.jrc.ec.europa.eu/repository/bitstream/JRC85145/fingerprint%20re%20for%20children%20final%20report%20%28pdf%29.pdf .
   Google Scholar
• Daugman JG. High confidence visual recognition of persons by a test of statistical independence. IEEE Trans Pattern Anal Mach Intell. 1993;15(11):1148–61. doi:10.1109/34.244676.
   Web of Science ®Google Scholar
• Giusti M ‘Golden Age’ for iris recognition? SecureID news. AVISIAN Publications. [accessed 2021 Jan 19]. https://www.secureidnews.com/news-item/golden-age-for-iris-recognition/.
   Google Scholar
• World Health Organization. Ebola virus disease fact sheet. 2018 [accessed 2020 Oct]. http://www.who.int/mediacentre/factsheets/fs103/en/ .
   Google Scholar
• Jacobs JA, Van Ranst M. Biometric fingerprinting for visa application: device and procedure are risk factors for infection transmission. J Travel Med. 2008;15(5):335–43. doi:10.1111/j.1708-8305.2008.00232.x.
   PubMed Web of Science ®Google Scholar
• Hall AK, Cole-Lewis H, Bernhardt JM. Mobile Text Messaging for Health: a Systematic Review of Reviews. Annu Rev Public Health. 2015;18(36):393–415. doi:10.1146/annurev-publhealth-031914-122855.
   Web of Science ®Google Scholar
• World Health Organization. Ebola health update – DRC. 2019 [accessed 2021 Jan 19]. https://www.who.int/emergencies/diseases/ebola/drc-2019 .
   Google Scholar
• World Health Organization. Ebola Virus Disease, Democratic Republic of the Congo, External Situation Report 45. 2019 [accessed 2021 Jan 19]. https://apps.who.int/iris/bitstream/handle/10665/325242/SITREP_EVD_DRC_UGA_20190612-eng.pdf?ua=1 .
   Google Scholar
• Pollard AJ, Launay O, Lelievre JD, Lacabaratz C, Grande S, Goldstein N, Robinson C, Gaddah A, Bockstal V, Wiedemann A, et al. EBOVAC2 EBL2001 study group. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis. 2020 Nov 17;S1473-3099(20)30476-X. [ Epub ahead of print. PMID: 33217361]. doi:10.1016/S1473-3099(20)30476-X.
   Web of Science ®Google Scholar
• Ebovac projects. The vaccines. [accessed 2021 Mar 17]. https://www.ebovac.org/the-vaccines/.
   Google Scholar
• World Health Organization. Strategic Advisory Group of Experts (SAGE) on Immunization Interim Recommendations on Vaccination against Ebola Virus Disease (EVD). 2019c May 7 [accessed 2021 Jan 19]. https://www.who.int/immunization/policy/position_papers/interim_ebola_recommendations_may_2019.pdf?ua=1&ua=1.
   Google Scholar
• Inungu J, Iheduru-Anderson K, Odio OJ. Recurrent Ebolavirus disease in the Democratic Republic of Congo: update and challenges. AIMS Public Health. 2019;6:502–13. doi:10.3934/publichealth.2019.4.502.
   PubMed Web of Science ®Google Scholar
• Anywaine Z, Whitworth H, Kaleebu P, Praygod G, Shukarev G, Manno D, Kapiga S, Grosskurth H, Kalluvya S, Bockstal V, et al. Safety and Immunogenicity of a 2-dose heterologous vaccination regimen with Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-month data from a Phase 1 randomized clinical trial in Uganda and Tanzania. J Infect Dis. 2019;220:46–56. doi:10.1093/infdis/jiz070.
   PubMed Web of Science ®Google Scholar
• Mutua G, Anzala O, Luhn K, Robinson C, Bockstal V, Anumendem D, Douoguih M. Safety and Immunogenicity of a 2-dose heterologous vaccine regimen with Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-month data from a Phase 1 randomized clinical trial in Nairobi, Kenya. J Infect Dis. 2019;220:57–67. doi:10.1093/infdis/jiz071.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li J, Hu Y, Liang Q, Wei M, Zhu F. Ebola vaccines in clinical trial: the promising candidates. Hum Vacc Immuno. 2017;13:153–68. doi:10.1080/21645515.2016.1225637.
   PubMed Web of Science ®Google Scholar
• Rwanda Ministry of Health. The Ministry of Health launched UMURINZI Ebola Vaccine Program Campaign. 2019 Sept 12 [accessed 2021 Jan 19]. https://moh.gov.rw/index.php?id=19&tx_news_pi1%5Bnews%5D=99&tx_news_pi1%5Bday%5D=9&tx_news_pi1%5Bmonth%5D=12&tx_news_pi1%5Byear%5D=2019&cHash=3ba2f0147e07d852c32a087d336276a8 .
   Google Scholar
• European Medicines Agency. New vaccine for prevention of Ebola virus disease recommended for approval in the European Union. [accessed 2021 Jan 19]. https://www.ema.europa.eu/en/news/new-vaccine-prevention-ebola-virus-disease-recommended-approval-european-union. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1248 .
   Google Scholar
• Innovative Medicines Initiative. Ebola+. 2020 [accessed 2021 Jan 19]. https://www.imi.europa.eu/projects-results/project-factsheets/ebola .
   Google Scholar
• Social Science in Humanitarian Action. Rwanda – DRC cross border dynamics. 2019 Apr [accessed 2021 Jan 19]. https://reliefweb.int/sites/reliefweb.int/files/resources/SSHAP%20-%20Cross-border%20dynamics%2C%20Rwanda-DRC.PDF .
   Google Scholar
• Smout B, Schulz W, Larson H, Willems A, Mc Kenna P. A guidebook on community engagement, communications, and technology for clinical trials in outbreak settings. [accessed 2021 Jan 19]. https://static1.squarespace.com/static/5d4d746d648a4e0001186e38/t/5da9a8b0da5d5c5fdd6d6f30/1571399935098/EBODAC+Guidebook-2018-06-07_v04_final.pdf .
   Google Scholar
• Masyn S, Vuchelen A, Santermans E, Rasschaert F, Bangura A, Parys W, Rutten R. Overcoming the Challenges of Iris Scanning to Identify Minors (1-4 Years) in the Real-World Setting. BMC Res Notes. 2019;12:448. doi:10.1186/s13104-019-4485-8.
   PubMed Web of Science ®Google Scholar
• Rukanda G, Amponsah M, Banura E, Kanwagi R, Gogo Egoeh S, Ngoka E, Babughirana G. Mobile phone automated messaging service’s and the fulfilment of planned clinical appointments: lessons from an Ebola clinical study in Kambia district, Sierra Leone. Int J Inform Commun Sci. 2021;6:1–10.
   Google Scholar
• Bull S, Ezeanochie N. From Foucault to Freire through Facebook: toward an integrated theory of mHealth. Health Educ Behav. 2016;43:399–411. doi:10.1177/1090198115605310.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Ebola Virus Disease, Democratic Republic of the Congo, External Situation Report 98. 2020c [accessed 2021 Jan 19]. https://www.who.int/publications/i/item/10665-332654 .
   Google Scholar
• Phares CR, Date K, Travers P, Déglise C, Wongjindanon N, Ortega L, Bhuket PR. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand. Vaccine. 2016;34:128–33. doi:10.1016/j.vaccine.2015.10.112.
   PubMed Web of Science ®Google Scholar
• Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, Neira M, Ivanoff B. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ. 1999;77:837–42.
   PubMed Web of Science ®Google Scholar
• Semá Baltazar C, Rafael F, Langa JPM, Chicumbe S, Cavailler P, Gessner BD, Pezzoli L, Barata A, Zaina D, Inguane DL, et al. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique. PLoS One. 2018;13:e0198592. doi:10.1371/journal.pone.0198592.
   PubMed Web of Science ®Google Scholar
• Dada S, McKay G, Mateus A, Lees S. Lessons learned from engaging communities for Ebola vaccine trials in Sierra Leone: reciprocity, relatability, relationships and respect (the four R’s). BMC Public Health. 2019;19:1665. doi:10.1186/s12889-019-7978-4.
   PubMed Web of Science ®Google Scholar
• World Health Organization. COVID-19 media briefing. Mar 2020b [accessed 2021 Jan 19]. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020 .
   Google Scholar
• Nelson R. COVID-19 disrupts vaccine delivery. Lancet Infect Dis. 2020;20:546. doi:10.1016/S1473-3099(20)30304-2.
   PubMed Web of Science ®Google Scholar
• Carlaw S. Impact on biometrics of Covid-19. Biometric Technol Today. 2020;2020:8–9. doi:10.1016/S0969-4765(20)30050-3.
   Google Scholar